RE: Hey "UN Boy"...........SWYG,
You have a comprehension problem, methinks. I never compared the merits of WNV vs EAA/Toraymyxin. I was commenting on your persistence at flogging this stock over the years!
You were an unadulterated pumper 4 years ago with WNV:
Up here Alberta has new concernsfor the disease as warm temps have created ideal conditions for WNV .Regardless of the revenue this will generate , the right mix of USacceptance ( beyond FDA ) and surging WNV cases , will easily take usover the 1.28 high from January . The biggest problem will be gettingyour hands on stock -> what a wonderful problem for existingshareholders to observe .As a person that has bought this at $9 in the past , I am amazed at thecurrent trading volumes given the 24.2M o/s shares . Very few sharesremain in the hands of people with MTRs ( marginal tax rates ) less than46.41% .AS I've maintained for many years , don't look at share price , look atmarket cap -> it becomes much more attractive from this angle .Cheers ,Sqr
I think that EAA/Toray has much more potential than WNV ( in hindsight-20/20) but they have to convince the FDA. Even with the FDA approval of WNV, we didn't get anywhere near 1.28 and still haven't but you never know. Us peons might make a buck or two yet, if they keep the interest going.